Knowledge, Skill and Attitude of Nurses on the COVID-19 Pandemic Crisis in Jazan, Saudi Arabia: A Quantitative Cross-Sectional Study
Coronavirus (COVID-19) was identified in the Chinese city of Wuhan in 2019. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and it is now recognized that SARS COV-2 may infect and spread among humans. During the pandemic situation, nurses and health care workers (HCWs) played a vital role in handling the infected patients and this study was carried out in Jazan city of Saudi Arabia among the nurses. The purpose of this study was to document nurses’ knowledge, skills, challenges, and information on the COVID-19. In this questionnaire-based study, we have enrolled 296 nurses based on inclusion and exclusion criteria. The 296 nurses involved in this study has shared their knowledge, experience, skills and challenges in handling the infected patients with COVID-19. Initially, 34.1% of nurses was expecting COVID-19 virus will be controlled by vaccine. The majority of nurses, 54.7%, were convinced that antibiotics could control the illness. In this study results, 97% of nurses were aware of COVID-19 symptoms such as fever, cough, sore throat, and shortness of breath. Around 96.3% of the nurses were aware of the risk of chronic diseases in the elderly population, which may be at risk of COVID-19 infection. The 78.7% nurses believed that mask can protect from the infecting from COVID-19 and ~94% of the nurses believed that avoiding of gatherings at public places is the best method to control the virus. The majority of the 97% of nurses believed that isolation is the best method to control the COVID-19 virus in an infected person. Nurses played a critical role in the treatment of COVID 19 infected patients in Saudi Arabia, as nurses and HCWs were at risk of becoming asymptomatic carriers due to their role in disease transmission. This study recommends the nurses, HCWs and all the residents of Saudi Arabia to take the vaccine to prevent the spread of COVID-19 as new strains are developing in the global population